Literature DB >> 10457913

alpha 2-Urinary globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats.

J A Swenberg1, L D Lehman-McKeeman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457913

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


× No keyword cloud information.
  6 in total

1.  alpha 2u-globulin nephropathy and renal tumors in national toxicology program studies.

Authors:  Adriana M Doi; Georgette Hill; John Seely; James R Hailey; Grace Kissling; John R Bucher
Journal:  Toxicol Pathol       Date:  2007-06       Impact factor: 1.902

2.  Epidemiologic characteristics and risk factors for renal cell cancer.

Authors:  Loren Lipworth; Robert E Tarone; Lars Lund; Joseph K McLaughlin
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

3.  Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference.

Authors:  Hans-Olov Adami; Sir Colin L Berry; Charles B Breckenridge; Lewis L Smith; James A Swenberg; Dimitrios Trichopoulos; Noel S Weiss; Timothy P Pastoor
Journal:  Toxicol Sci       Date:  2011-05-10       Impact factor: 4.849

4.  Summary of Toxicity Studies with Flutianil.

Authors:  Naoki Ikemi; Sachi Kimura; Yasuhiro Endo; Hisashi Oka
Journal:  J Pestic Sci       Date:  2019-07-25       Impact factor: 2.529

5.  Streptozotocin induces alpha-2u globulin nephropathy in male rats during diabetic kidney disease.

Authors:  Kanchana Kengkoom; Wannee Angkhasirisap; Tapanee Kanjanapruthipong; Rongdej Tungtrakanpoung; Khwanchanok Tuentam; Naphatson Phansom; Sumate Ampawong
Journal:  BMC Vet Res       Date:  2021-03-04       Impact factor: 2.741

6.  Binding of ochratoxin A to a urinary globulin: a new concept to account for gender difference in rat nephrocarcinogenic responses.

Authors:  Peter G Mantle; Judit Nagy
Journal:  Int J Mol Sci       Date:  2008-05-08       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.